tailieunhanh - Post hoc analysis of the glutamics–trial: Intravenous glutamate infusion and use of inotropic drugs after cabg

Intravenous glutamate reduced the risk of developing severe circulatory failure after isolated coronary artery bypass graft surgery (CABG) for acute coronary syndrome (ACS) in a double-blind randomised clinical trial ( Identifier:NCT00489827). Here our aim was to study if glutamate was associated with reduced the use of inotropes. |

TỪ KHÓA LIÊN QUAN